Skip to main content

Want a detailed portfolio tracker?

Janux Therapeutics (JANX) P/E (2021 - 2026)

Janux Therapeutics (JANX) P/E from Jun 30, 2021 to Jul 20, 2026. The TTM Janux Therapeutics (JANX) P/E is -8.43. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Janux Therapeutics (JANX)

YearP/EChange
2026-8.43+16.13%
2025-7.26-82.69%
2024-41.91+475.26%
2023-7.29-19.33%
2022-9.03-66.21%
2021-26.73N/A

Comparison Janux Therapeutics (JANX) P/E with competitors

Janux Therapeutics (JANX) P/E is -8.43.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.00-100.05%
ENLVEnlivex Ltd0.07-100.89%
FGENFibroGen Inc0.24-102.85%
CHRSCoherus Biosciences Inc0.85-110.07%
FBIOFortress Biotech Inc0.95-111.26%
ORMPOramed Pharmaceuticals Inc1.50-117.84%
AGENAgenus Inc3.01-135.71%
INVAInnoviva Inc3.15-137.43%
VXRTVaxart Inc3.55-142.12%
CRMDCorMedix Inc3.63-143.06%
CVACCureVac N.V.4.45-152.76%
GLPGGalapagos NV4.86-157.66%
SRPTSarepta Therapeutics Inc4.88-157.93%
ABEOAbeona Therapeutics Inc5.39-163.93%
ABUSArbutus Biopharma Corp5.60-166.40%
ZVRAZevra Therapeutics Inc5.89-169.86%
SPROSpero Therapeutics Inc6.23-173.91%
CGENCompugen Ltd6.31-174.93%
RIGLRigel Pharmaceuticals6.87-181.55%
SLXNSilexion Therapeutics Corp7.30-186.58%
OMEROmeros Corporation9.26-209.87%
AUPHAurinia Pharmaceuticals Inc9.58-213.74%
PLXProtalix BioTherapeutics Inc10.89-229.24%
ACADAcadia Pharmaceuticals Inc11.73-239.18%
TBPHTheravance Biopharma Inc12.26-245.51%
ADMAAdma Biologics Inc12.42-247.36%
HRMYHarmony Biosciences Holdings Inc13.82-264.00%
SABSSAB Biotherapeutics Inc14.14-267.75%
NAGENiagen Bioscience Inc14.82-275.84%
INCYIncyte Corp15.82-287.76%
REGNRegeneron Pharmaceuticals Inc15.86-288.17%
PBYIPuma Biotechnology Inc17.32-305.48%
CPRXCatalyst Pharmaceuticals Inc17.44-306.95%
EXELExelixis Inc17.54-308.12%
TGTXTG Therapeutics Inc18.97-325.07%
MDXGMimedx Group Inc20.55-343.89%
XOMAXOMA Royalty Corp22.87-371.46%
ARGXArgen X SE24.30-388.35%
CTMXCytomX Therapeutics Inc24.82-394.55%
XOMAOXOMA Royalty Corp25.34-400.77%
HALOHalozyme Therapeutics Inc25.62-404.08%
XOMAPXOMA Royalty Corp25.67-404.63%
VRTXVertex Pharmaceuticals Inc27.99-432.22%
RPRXRoyalty Pharma plc - Class A28.69-440.44%
SLNOSoleno Therapeutics Inc29.02-444.33%
ASNDAscendis Pharma A/S30.09-457.03%
LGNDLigand Pharmaceuticals Inc - Class B37.91-549.91%
APLSApellis Pharmaceuticals Inc39.02-563.07%
BMRNBiomarin Pharmaceutical Inc42.21-600.93%
KRYSKrystal Biotech Inc45.34-638.10%
ONCBeiGene Ltd69.54-925.24%
PHARPharming Group N.V.75.03-990.34%
TECHBio-Techne Corp101.96-1309.95%
VCELVericel Corp109.92-1404.45%
ALNYAlnylam Pharmaceuticals Inc117.96-1499.91%
GMABGenmab140.29-1764.85%
TLXTelix Pharmaceuticals Ltd162.15-2024.29%
CORTCorcept Therapeutics Inc212.86-2626.01%